The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.

Abstract

Complex immune contexture leads to resistance to immunotherapy in hepatocellular carcinoma (HCC), and the need for new potential biomarkers of immunotherapy in HCC is urgent. Histone chaperones are vital determinants of gene expression and genome stability that regulate tumor development. This study aimed to investigate the effect of histone chaperones on tumor immunity in HCC. Bioinformatics analyses were initially performed using The Cancer Genome Atlas (TCGA) database, and were validated using the Gene Expression Omnibus (GEO) database and the International Cancer Genome Consortium (ICGC) database. Immune-related histone chaperones were screened with the Spearman rank coefficient. Consensus clustering was utilized to divide the HCC samples into two clusters. ESTIMATE, CIBERSORT and ssGSEA analyses were performed to assess immune infiltration. The expression of immunomodulatory genes, chemokines and chemokine receptors was analyzed to evaluate sensitivity to immunotherapy. The differentially expressed genes (DEGs) were included in weighted gene coexpression network analysis (WGCNA) to identify the hub genes. Enrichment analyses were used to investigate the functions of the hub genes. The Kaplan-Meier method and log-rank test were conducted to draw survival curves. A Cox regression analysis was utilized to identify independent risk factors affecting prognosis. HSPA8 and DEK were screened out from 36 known histone chaperones based on their strongest correlation with the ESTIMATE score. Cluster 2, with high HSPA8 expression and low DEK expression, tended to have stronger immune infiltration and better sensitivity to immunotherapy than Cluster 1, with low HSPA8 expression and high DEK expression. Furthermore, WGCNA identified 12 hub genes closely correlated with immune infiltration from the DEGs of the two clusters, of which FBLN2 was proven to be an independent protective factor of HCC patients. HSPA8 and DEK are expected to be biomarkers for precisely predicting the effect of immunotherapy, and FBLN2 is expected to be a therapeutic target of HCC.

• Authors: Chuanxin Yang, Yaodi Shao, Xiangjun Wang, Jie Wang, Puxiongzhi Wang, Chao Huang, Wei Wang, Jian Wang
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 24 Issue 3 (Jan 31 2023) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 36768989 (Publication Type: Journal Article)

Chemical References

• Antigen-Antibody Complex
• Biomarkers, Tumor
• Dek protein, human
• Poly-ADP-Ribose Binding Proteins
• Chromosomal Proteins, Non-Histone
• Oncogene Proteins
• HSPA8 protein, human
• HSC70 Heat-Shock Proteins

Topics

• Humans
• Carcinoma, Hepatocellular (genetics)
• Liver Neoplasms (genetics)
• Immunotherapy
• Antigen-Antibody Complex
• Cluster Analysis
• Biomarkers, Tumor (genetics)
• Gene Expression Regulation, Neoplastic
• Poly-ADP-Ribose Binding Proteins
• Chromosomal Proteins, Non-Histone (genetics)
• Oncogene Proteins (genetics)
• HSC70 Heat-Shock Proteins